IMR Press / EJGO / Volume 40 / Issue 5 / DOI: 10.12892/ejgo5111.2019
Open Access Review
Hypoxia and its importance in the course of gynaecological cancers
Show Less
1 Department of Perinatology and women's Diseases, Poznan University of Medical Sciences, Poland
2 Department of Oncology, Poznan University of Medical Sciences, Poland
3 Faculty of Chemistry, Adam Mickiewicz University, Poznan, Poland
4 Department of Gynecology Oncology, Center of Oncology M. Sklodowska-Curie Institute, Cracow Branch, Poland
5 Swedish Orphan Biovitrum Ltd., warsaw, Poland
Eur. J. Gynaecol. Oncol. 2019, 40(5), 711–713;
Published: 10 October 2019

Hypoxia-oxygen deficiency is a feature of most solid malignant tumours. This leads to the selection of an aggressive neoplasm phenotype by activating molecular factors including hypoxia inducible factor 1α (HIF-1α), vascular endothelial growth factor (VEGF) promoting angiogenesis, and also by the influence of the tumour microenvironment, no possibility of fixation of DNA damage after radio- and chemotherapy, and the change in cadherin activity. Another mechanism of hypoxia facilitates the survival, and activity of cancer stem cells (CSCs). The described therapies eliminating hypoxia include the use of cytotoxins, anaerobic bacteria, YC-1 factor, arsenic trioxide (As2O3), and eradication of CSCs by using retinoic and ursolic acid. The paper describes hypoxia as the cause of failure in the treatment of gynaecological cancers and therapies eliminating it.

Hypoxia-oxygen deficiency
Gynaecological cancers
Back to top